Network pharmacology analysis reveals that quercetin regulates MAPK, IL-17, and phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) signaling pathways for cardiovascular disease treatment (Wu et al., 2019). Here, IL17A is linked to cardiovascular disorder.